Cargando…
Inflammasome Activation-Induced Hypercoagulopathy: Impact on Cardiovascular Dysfunction Triggered in COVID-19 Patients
Coronavirus disease 2019 (COVID-19) is the most devastating infectious disease in the 21st century with more than 2 million lives lost in less than a year. The activation of inflammasome in the host infected by SARS-CoV-2 is highly related to cytokine storm and hypercoagulopathy, which significantly...
Autores principales: | Gedefaw, Lealem, Ullah, Sami, Leung, Polly H. M., Cai, Yin, Yip, Shea-Ping, Huang, Chien-Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073302/ https://www.ncbi.nlm.nih.gov/pubmed/33923537 http://dx.doi.org/10.3390/cells10040916 |
Ejemplares similares
-
Targeting Inflammasome Activation in COVID-19: Delivery of RNA Interference-Based Therapeutic Molecules
por: Gedefaw, Lealem, et al.
Publicado: (2021) -
Value of thromboelastography in managing hypercoagulopathy in intensive care
por: Aron, J, et al.
Publicado: (2015) -
Blood Biomarkers as Prognostic Indicators for Neurological Injury in COVID-19 Patients: A Systematic Review and Meta-Analysis
por: Huang, Zhiwei, et al.
Publicado: (2023) -
Artificial Intelligence-Assisted Diagnostic Cytology and Genomic Testing for Hematologic Disorders
por: Gedefaw, Lealem, et al.
Publicado: (2023) -
Tissue Hypoperfusion, Hypercoagulopathy, and Kidney and Liver Dysfunction after Ingestion of a Naphazoline-Containing Antiseptic
por: Ono, Yuko, et al.
Publicado: (2017)